BEYOND AIR: STRONG UPCOMING CATALYSTS MAKE THIS A MUST WATCH Beyond Air (NASDAQ:XAIR) is a clinical-stage biopharmaceutical and medical device company that uses a proprietary technology to produce nitric oxide from ambient air through its LungFit System.
The Company has major upcoming catalysts that include the US FDA approval of LungFit:registered: PH ventilator compatible and interim data readouts from Acute viral pneumonia (including COVID19) and Nontuberculous mycobacteria (NTM) lung infection. The Company intends to launch e first in human studies in Multiple Solid Tumors by the end of 2021.
The Company's breakthrough technology can be a potential disruptor in the delivery of Nitric Oxide!
https://www.aviseanalytics.com/beyond-air-strong-upcoming-catalysts-make-this-a-must-watch/